Prognostic Value of APACHE IV Score in Patients Bridged to Heart Transplantation on ECMO
Clinical Transplantation · 2024
DOI: 10.1111/ctr.15370 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Clinical Transplantation, 2024. Verfasst von Andrea Lechiancole und 15 weiteren Autor:innen. Beteiligte Einrichtung: Cardiothoracic Department, University Hospital, Udine, Italy. Hauptthemen laut MEDLINE: Extracorporeal Membrane Oxygenation, Heart Transplantation, APACHE. Die Arbeit nennt 28 Literaturangaben.
Abstract (Originalsprache)
Background
Methods for risk stratification of candidates for heart transplantation (HTx) supported by extracorporeal membrane oxygenation (ECMO) are limited. We evaluated the reliability of the APACHE IV score to identify the risk of mortality in this patient subset in a multicenter study.
Methods
Between January 2010 and December 2022, 167 consecutive ECMO patients were bridged to HTx; they were divided into two groups, according to a cutoff value of APACHE IV score, obtained by receiver operating characteristic curve analysis for 90‐day mortality. Kaplan–Meier survival curves were plotted, and compared through the log‐Rank test. Cox regression model was used to estimate which factors were associated with survival.
Results
The 90‐day mortality prediction of the APACHE IV score showed an area under the curve of 0.87 (95% CI: 0.80–0.94), with a cutoff value of 49 (specificity 91.7%–sensibility 69.6%). 125 patients (74.8%) showed an APACHE IV score value < 49 (Group A), and 42 (25.2%) ≥ 49 (Group B). 90‐day mortality was 11.2% in Group A and 76.2% in Group B ( p < 0.01). Survival at 1 and 5 years was 85.5%, 77% versus 23.4%, 23.4% ( p < 0.01) in Groups A and B. Mortality correlated at univariable analysis with recipient age, body mass index, mechanical ventilation, APACHE IV score, and platelets number. At multivariable analysis only APACHE IV score (HR: 1.07 [1.05–1.09, 95% CI]) independently affected survival.
Conclusions
The APACHE IV score represents a powerful predictor of survival in patients bridged to HTx on ECMO support, and could guide candidacy of patients on ECMO.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cardiothoracic Department, University Hospital, Udine, Italy.
- Cardiac Surgery Unit, Niguarda Hospital, Milan, Italy.
- Department of Cardiac Surgery, University of Siena, Siena, Italy.
- Division of Cardiology, University of Siena, Siena, Italy.
- Division of Cardiac Surgery, University Hospital, Bologna, Italy.
- Cardiac Surgery Division, University of Turin, Turin, Italy.
ORCID-Profile: Andrea Lechiancole, Guido M Olivieri, Massimo Boffini, Matteo Marro
Zitieren
APA
Lechiancole, A., Russo, C. F., Olivieri, G. M., Maccherini, M., Valente, S., Pacini, D., Suarez, S. M., Boffini, M., Marro, M., Pelenghi, S., Totaro, P., Isola, M., Martino, M., Bortolotti, U., Livi, U., & Vendramin, I. (2024). Prognostic Value of APACHE IV Score in Patients Bridged to Heart Transplantation on ECMO. Clinical Transplantation. https://doi.org/10.1111/ctr.15370
Vancouver
Lechiancole A, Russo CF, Olivieri GM, Maccherini M, Valente S, Pacini D, et al. Prognostic Value of APACHE IV Score in Patients Bridged to Heart Transplantation on ECMO. Clinical Transplantation. 2024. doi:10.1111/ctr.15370
BibTeX
@article{Lechiancole2024,
author = {Lechiancole, Andrea and Russo, Claudio F and Olivieri, Guido M and Maccherini, Massimo and Valente, Serafina and Pacini, Davide and Suarez, Sofia Martin and Boffini, Massimo and Marro, Matteo and Pelenghi, Stefano and Totaro, Pasquale and Isola, Miriam and Martino, Maria De and Bortolotti, Uberto and Livi, Ugolino and Vendramin, Igor},
title = {Prognostic Value of APACHE IV Score in Patients Bridged to Heart Transplantation on ECMO},
journal = {Clinical Transplantation},
year = {2024},
doi = {10.1111/ctr.15370}
}
EUVIMED